Authors: Body, JJ Louviaux, I Dumon, JC

Citation: Jj. Body et al., Decreased efficacy of bisphosphonates for recurrences of tumor-induced hypercalcemia, SUPP CARE C, 8(5), 2000, pp. 398-404

Authors: Van den Neste, E Louviaux, I Michaux, JL Delannoy, A Michaux, L Sonet, A Bosly, A Doyen, C Mineur, P Andre, M Straetmans, N Coche, E Venet, C Duprez, T Ferrant, A

Citation: E. Van Den Neste et al., Phase I/II study of 2-chloro-2 '-deoxyadenosine with cyclophosphamide in patients with pretreated B cell chronic lymphocytic leukemia and indolent. non-Hodgkin's lymphoma, LEUKEMIA, 14(6), 2000, pp. 1136-1142

Authors: Louviaux, I Van Den Neste, E Scheiff, JM Michaux, L Straetmans, N Ferrant, A

Citation: I. Louviaux et al., Digital clubbing in a patient with progressive mantle cell lymphoma, ANN HEMATOL, 78(1), 1999, pp. 29-31

Authors: Van Den Neste, E Bontemps, F Delacauw, A Cardoen, S Louviaux, I Scheiff, JM Gillis, E Leveugle, P Deneys, V Ferrant, A Van den Berghe, G

Citation: E. Van Den Neste et al., Potentiation of antitumor effects of cyclophosphamide derivatives in B-chronic lymphocytic leukemia cells by 2-chloro-2 '-deoxyadenosine, LEUKEMIA, 13(6), 1999, pp. 918-925

Authors: Van Den Neste, E Louviaux, I Michaux, JL Delannoy, A Michaux, L Hagemeijer, A Scheiff, JM Bosly, A Straetmans, N Ferrant, A

Citation: E. Van Den Neste et al., Myelodysplastic syndrome with monosomy 5 and/or 7 following therapy with 2-chloro-2 '-deoxyadenosine, BR J HAEM, 105(1), 1999, pp. 268-270